View in EDS HTML Full Text PDF Full Text

Chemoprevention agents for melanoma: A path forward into phase 3 clinical trials.

Saved in:
Bibliographic Details
Title: Chemoprevention agents for melanoma: A path forward into phase 3 clinical trials.
Authors: Jeter JM; Department of Medicine, Divisions of Genetics and Oncology, The Ohio State University, Columbus, Ohio., Bowles TL; Department of Surgery, Intermountain Health Care, Huntsman Cancer Institute, University of Utah Health Sciences Center, Salt Lake City, Utah., Curiel-Lewandrowski C; Department of Medicine, The University of Arizona Cancer Center, Tucson, Arizona., Swetter SM; Department of Dermatology, Pigmented Lesion and Melanoma Program, Stanford University Medical Center Cancer Institute, Veterans Affairs Palo Alto Health Care System, Palo Alto, California., Filipp FV; Systems Biology and Cancer Metabolism, Program for Quantitative Systems Biology, University of California Merced, Merced, California., Abdel-Malek ZA; Department of Dermatology, University of Cincinnati, Cincinnati, Ohio., Geskin LJ; Department of Dermatology, Cutaneous Oncology Center, Columbia University Medical Center, New York, New York., Brewer JD; Department of Dermatologic Surgery, Mayo Clinic Minnesota, Rochester, Minnesota., Arbiser JL; Department of Dermatology, Emory University School of Medicine, Atlanta, Georgia.; Division of Dermatology, Veterans Affairs Medical Center, Atlanta, Georgia., Gershenwald JE; Departments of Surgical Oncology and Cancer Biology, Melanoma and Skin Cancer Center, The University of Texas MD Anderson Cancer Center, Houston, Texas., Chu EY; Department of Dermatology, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania., Kirkwood JM; Melanoma and Skin Cancer Program, Department of Medicine, University of Pittsburgh Cancer Institute, Pittsburgh, Pennsylvania., Box NF; Department of Dermatology, University of Colorado Anschutz Medical Campus, Aurora, Colorado.; Dermatology Service, U.S. Department of Veterans Affairs, Eastern Colorado Health Care System, Denver, Colorado.; Department of Epidemiology, Colorado School of Public Health, University of Colorado Anschutz Medical Campus, Aurora, Colorado., Funchain P; Taussig Cancer Institute, Cleveland Clinic, Cleveland, Ohio., Fisher DE; Department of Dermatology, Massachusetts General Hospital, Boston, Massachusetts., Kendra KL; Department of Internal Medicine, Medical Oncology Division, The Ohio State University, Columbus, Ohio., Marghoob AA; Memorial Sloan Kettering Skin Cancer Center and Department of Dermatology, Memorial Sloan Kettering Cancer Center, New York, New York., Chen SC; Department of Dermatology, Emory University School of Medicine, Atlanta, Georgia.; Division of Dermatology, Veterans Affairs Medical Center, Atlanta, Georgia., Ming ME; Department of Dermatology, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania., Albertini MR; Department of Medicine, University of Wisconsin, School of Medicine and Public Health, University of Wisconsin Carbone Cancer Center, William S. Middleton Memorial Veterans Hospital, Madison, Wisconsin., Vetto JT; Division of Surgical Oncology, Oregon Health & Science University, Portland, Oregon., Margolin KA; Department of Medical Oncology, City of Hope National Medical Center, Duarte, California., Pagoto SL; Department of Allied Health Sciences, UConn Institute for Collaboration in Health, Interventions, and Policy, University of Connecticut, Storrs, Connecticut., Hay JL; Department of Psychiatry and Behavioral Sciences, Memorial Sloan Kettering Cancer Center, New York, New York., Grossman D; Departments of Dermatology and Oncological Sciences, Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah., Ellis DL; Department of Dermatology, Vanderbilt University Medical Center and Division of Dermatology, Vanderbilt Ingram Cancer Center, Nashville, Tennessee.; Department of Medicine, Tennessee Valley Healthcare System, Nashville Veterans Affairs Medical Center, Nashville, Tennessee., Kashani-Sabet M; Center for Melanoma Research and Treatment, California Pacific Medical Center, San Francisco, California., Mangold AR; Department of Dermatology, Mayo Clinic, Scottsdale, Arizona., Markovic SN; Department of Hematology and Oncology, Mayo Clinic, Rochester, Minnesota., Meyskens FL Jr, Nelson KC; Department of Dermatology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Powers JG; Department of Dermatology, University of Iowa, Iowa City, Iowa., Robinson JK; Department of Dermatology, Northwestern University Feinberg School of Medicine, Chicago, Illinois., Sahni D; Department of Dermatology, Boston Medical Center, Boston, Massachusetts., Sekulic A; Department of Dermatology, Mayo Clinic, Scottsdale, Arizona., Sondak VK; Department of Cutaneous Oncology, H. Lee Moffitt Cancer Center, Tampa, Florida.; Departments of Oncologic Sciences and Surgery, University of South Florida Morsani College of Medicine, Tampa, Florida., Wei ML; Department of Dermatology, University of California, San Francisco, San Francisco, California.; Dermatology Service, San Francisco Veterans Affairs Medical Center, San Francisco, California., Zager JS; Department of Cutaneous Oncology, H. Lee Moffitt Cancer Center, Tampa, Florida.; Department of Sarcoma, H. Lee Moffitt Cancer Center, Tampa, Florida., Dellavalle RP; Department of Dermatology, University of Colorado Anschutz Medical Campus, Aurora, Colorado.; Dermatology Service, U.S. Department of Veterans Affairs, Eastern Colorado Health Care System, Denver, Colorado.; Department of Epidemiology, Colorado School of Public Health, University of Colorado Anschutz Medical Campus, Aurora, Colorado., Thompson JA; Fred Hutchinson Cancer Research Center, University of Washington, Seattle, Washington., Weinstock MA; Center for Dermatoepidemiology, Veterans Affairs Medical Center, Providence, Rhode Island.; Department of Dermatology, Brown University, Providence, Rhode Island.; Department of Epidemiology, Brown University, Providence, Rhode Island.; Department of Dermatology, Rhode Island Hospital, Providence, Rhode Island., Leachman SA; Department of Dermatology, Knight Cancer Institute, Oregon Health & Science University, Portland, Oregon., Cassidy PB; Department of Dermatology, Knight Cancer Institute, Oregon Health & Science University, Portland, Oregon.
Source: Cancer [Cancer] 2019 Jan 01; Vol. 125 (1), pp. 18-44. Date of Electronic Publication: 2018 Oct 03.
Publication Type: Journal Article; Review
Journal Info: Publisher: Wiley Country of Publication: United States NLM ID: 0374236 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1097-0142 (Electronic) Linking ISSN: 0008543X NLM ISO Abbreviation: Cancer Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:1097-0142
DOI:10.1002/cncr.31719